Company intelligence / Profile preview

Aspida Dx

Horsham, Pennsylvania, United Statesaspida-dx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Aspida Dx has developed a compact, saliva-based diagnostic device capable of detecting up to 10 different illicit drugs quickly and non-invasively. The system can be operated by minimally trained personnel and provides fast, accurate results using advanced chemical reactions and laser technology[4][5].

Therapeutic areas: Other
Modalities: Device
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Aspida Dx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aspida Dx.

Explore the full profile